1564259168558751745

Multiple abstracts demonstrating potential improved outcomes, quality of life, access and health equity with our lead stem cell therapy pipeline candidate, #omidubicel were accepted for presentation at the #CordBloodConnect meeting in September.
Learn More https://t.co/3PqLY7hc8k https://t.co/D52Emq7kTW

Send us a message